[go: up one dir, main page]

MX2018000488A - Composicion de autoformacion de pelicula para el cuidado oral. - Google Patents

Composicion de autoformacion de pelicula para el cuidado oral.

Info

Publication number
MX2018000488A
MX2018000488A MX2018000488A MX2018000488A MX2018000488A MX 2018000488 A MX2018000488 A MX 2018000488A MX 2018000488 A MX2018000488 A MX 2018000488A MX 2018000488 A MX2018000488 A MX 2018000488A MX 2018000488 A MX2018000488 A MX 2018000488A
Authority
MX
Mexico
Prior art keywords
oral
film
self
forming composition
oral care
Prior art date
Application number
MX2018000488A
Other languages
English (en)
Inventor
Cuñé Castellana Jordi
Lázaro Mallén Elisabet;
Mareque Mareque Bueno Javier
Santas Gutiérrez Jonatan
Luis Calvo Guirado Jose
Original Assignee
Ab Biotics Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Biotics Sa filed Critical Ab Biotics Sa
Publication of MX2018000488A publication Critical patent/MX2018000488A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se proporciona una composición de autoformación de película en polvo, una fórmula reconstituida y un kit para uso oral, que permiten una colonización adecuada del probiótico en las cavidades orales junto con un tiempo de residencia suficiente para permitir efectos beneficiosos contra los patógenos relacionados con condiciones orales. Por lo tanto, los elementos proporcionados son útiles para la prevención y/o el tratamiento de una condición relacionada con las alteraciones de la microbiota oral, y específicamente para la periimplantitis. La composición de autoformación de película en forma de polvo comprende al menos un agente gelificante y/o al menos un agente bioadhesivo, y al menos una cepa de bacterias de ácido láctico.
MX2018000488A 2015-07-17 2016-07-11 Composicion de autoformacion de pelicula para el cuidado oral. MX2018000488A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15177318.1A EP3117822A1 (en) 2015-07-17 2015-07-17 Self-film-forming composition for oral care
PCT/EP2016/066456 WO2017012905A1 (en) 2015-07-17 2016-07-11 Self-film-forming composition for oral care

Publications (1)

Publication Number Publication Date
MX2018000488A true MX2018000488A (es) 2018-11-12

Family

ID=53716377

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018000488A MX2018000488A (es) 2015-07-17 2016-07-11 Composicion de autoformacion de pelicula para el cuidado oral.

Country Status (9)

Country Link
US (1) US11478423B2 (es)
EP (2) EP3117822A1 (es)
JP (1) JP6993967B2 (es)
CN (2) CN119656205A (es)
BR (1) BR112018000812A2 (es)
CA (1) CA2992354C (es)
ES (1) ES2994765T3 (es)
MX (1) MX2018000488A (es)
WO (1) WO2017012905A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018065324A1 (en) 2016-10-03 2018-04-12 Ab-Biotics, S.A. Antiseptic-tolerant lactic acid bacteria
WO2019053260A2 (en) * 2017-09-15 2019-03-21 Nobel Biocare Services Ag COMPOSITIONS AND FILMS FOR APPLICATION TO DENTAL SUBSTRATES
EP3549578A1 (en) 2018-04-06 2019-10-09 Bio Minerals N.V. Silicic acid formulation and use thereof
FR3085387B1 (fr) * 2018-09-05 2021-01-29 Inst Nat De La Rech Agronomique Inra Nouveau traitement de la mucite
CN110960559B (zh) * 2018-09-30 2021-02-26 内蒙古伊利实业集团股份有限公司 用于抑制口腔病原菌的乳酸菌菌株的食品、口腔清洁以及医药组合物
WO2020063531A1 (zh) 2018-09-30 2020-04-02 内蒙古伊利实业集团股份有限公司 副干酪乳杆菌et-22及其用途
EP3632449A1 (en) * 2018-10-05 2020-04-08 Bio Minerals N.V. Silicic acids for use in the treatment of periodontitis
JP2021052709A (ja) * 2019-10-01 2021-04-08 秀俊 西尾 マウスピース内での細菌培養方法、及び齲蝕・歯周病の予防又は治療方法
WO2021066094A1 (ja) * 2019-10-01 2021-04-08 医療法人社団プレシャスワン 歯のホワイトニング方法
CN113925885B (zh) * 2020-06-29 2024-06-04 创百股份有限公司 后生元提取物用于预防和/或治疗关节炎与关节退化的用途
IT202100001169A1 (it) * 2021-01-27 2022-07-27 Alfasigma Spa Gel mucoadesivo buccale contenente probiotici per uso nella prevenzione e nel trattamento delle malattie parodontali.
KR102439762B1 (ko) * 2021-03-09 2022-09-02 주식회사 오라팜 임플란트 주위점막염 예방 및 치료 조성물
IT202100010802A1 (it) * 2021-05-03 2022-11-03 Alfasigma Spa Formulazione solida mucoadesiva comprendente probiotici per uso nella prevenzione e nel trattamento di disbiosi orale.
CN114392238A (zh) * 2021-12-31 2022-04-26 广州星际悦动股份有限公司 用于口腔护理的冻干制剂、口腔护理产品及冲牙器
CN115160613B (zh) * 2022-08-17 2023-07-18 江苏省农业科学院 一种保鲜水凝膜的制备工艺
WO2026024703A1 (en) * 2024-07-22 2026-01-29 NovoMedTek LLC Chemical composition for oral applications
CN119709556A (zh) * 2025-02-26 2025-03-28 民生威曼(山东)动物健康科技有限公司 一种缓解宠物犬口腔异味的乳酸片球菌King01、菌剂及其应用
CN121203922A (zh) * 2025-12-01 2025-12-26 威凯海思(山东)生物工程有限公司 一株具有预防或治疗龋齿和牙周病功效的戊糖片球菌及其制剂和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005079210A2 (en) * 2003-12-04 2005-09-01 Biofilms Strategies, Inc. Methods and compositions for preventing biofilm formations, reducing existing biofilms, and for reducing existing biofilms, and for reducing populations of bacteria
FR2915388B1 (fr) * 2007-04-27 2010-12-24 Oreal Film hydrosoluble cosmetique
US20090041727A1 (en) * 2007-08-08 2009-02-12 Conjugon, Inc. Compositions and Methods for Microbe Storage and Delivery
US9636196B2 (en) * 2008-06-13 2017-05-02 ProBiora Health, LLC Use of hydrogen peroxide-producing bacteria for tooth whitening
JP2010053062A (ja) * 2008-08-28 2010-03-11 Sunstar Inc 口腔用組成物
MY157343A (en) * 2009-05-26 2016-05-31 Advanced Bionutrition Corp Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
KR20110017534A (ko) * 2009-08-14 2011-02-22 신미정 유산균 복합체를 이용한 치주 질환의 치료방법
EP2420580A1 (en) * 2010-08-18 2012-02-22 AB-Biotics, S.A. Probiotic composition for oral health

Also Published As

Publication number Publication date
BR112018000812A2 (pt) 2018-09-04
JP6993967B2 (ja) 2022-02-04
CN119656205A (zh) 2025-03-21
EP3324928C0 (en) 2024-09-04
EP3324928B1 (en) 2024-09-04
JP2018521136A (ja) 2018-08-02
US20190000757A1 (en) 2019-01-03
EP3324928A1 (en) 2018-05-30
EP3117822A1 (en) 2017-01-18
CN107920986A (zh) 2018-04-17
ES2994765T3 (en) 2025-01-31
WO2017012905A1 (en) 2017-01-26
CA2992354C (en) 2023-09-19
CA2992354A1 (en) 2017-01-26
US11478423B2 (en) 2022-10-25

Similar Documents

Publication Publication Date Title
MX2018000488A (es) Composicion de autoformacion de pelicula para el cuidado oral.
CL2018001549A1 (es) Mezcla de hmos
DOP2017000272A (es) Métodos de diagnóstico para tratamiento con linfocitos t
DOP2017000271A (es) Métodos de acondicionamiento de pacientes para tratamiento con linfocitos t
EA201690147A1 (ru) Пероральные композиции
CL2017003151A1 (es) Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
CL2015002755A1 (es) Composiciones antibióticas de ceftolozano.
UY35103A (es) Compuestos de cefem 2-sustituidos
MX2019012978A (es) Composiciones para el cuidado bucal y metodos para utilizar las composiciones.
WO2016086209A8 (en) Probiotic and prebiotic compositions, and methods of use thereof for treatment of gastrointestinal disorders
MX2016009898A (es) Tratamientos para acne resistente.
PE20211069A1 (es) Composicion que comprende 5'-metilselenoadenosina, selenoadenosil-l-homocisteina y gama glutamil-metilselenocisteina
BR112018014545A2 (pt) probióticos para uso como agentes anti-inflamatórios na cavidade oral
MX2019003787A (es) Bacterias del ácido láctico tolerantes a antisépticos.
MX354123B (es) Composición antiséptica oral para tratamiento de mucositis oral.
CL2018000963A1 (es) Cosmética que tiene bacterias probióticas
MX2017015247A (es) Metodos y composiciones para modular la microbiota intestinal y para manejar el peso.
AR098985A1 (es) Composiciones prebióticas para el cuidado oral contienen un alquilglucósido
MX379201B (es) Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
MX2018005489A (es) Agente antimicrobiano que comprende xantohumol y su uso en productos alimenticios.
CL2019002340A1 (es) Composiciones y métodos para promover el crecimiento del cabello con inhibidores de mpc1.
MX2020007462A (es) Metodos de tratamiento de enfermedades inflamatorias cronicas.
NI201700062A (es) Consorcios bacterianos sinergísticos para movilizar fósforo del suelo
AR102778A1 (es) Composición farmacéutica, su preparación y sus usos